How to Buy Alnylam Pharmaceuticals Stock
Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference.
Alnylam Pharmaceuticals stock last closed at $295.50, down 0.66% from the previous day, and has increased 1.86% in one year. It has overperformed other stocks in the Biotechnology industry by 0.77 percentage points. Alnylam Pharmaceuticals stock is currently +3.95% from its 52-week low of $284.28, and -40.37% from its 52-week high of $495.55.
There are currently 133.51M ALNY shares outstanding. The market value of ALNY is $39.45B. In the last 24 hours, 506,000 ALNY shares were traded.
How to Buy Alnylam Pharmaceuticals Stock
Wondering how to invest in Alnylam Pharmaceuticals stock? Here's how.
- Decide where to buy Alnylam Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Alnylam Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit money your brokerage account: Select your payment method and add your info.
- Evaluate Alnylam Pharmaceuticals stock: The Alnylam Pharmaceuticals ticker symbol is ALNY. Is Alnylam Pharmaceuticals stock a good investment? Should you buy shares of ALNY? How do ALNY's underlying business fundamentals look? Do top analysts think Alnylam Pharmaceuticals is a good buy? Why has ALNY's stock price moved recently? (Hint: Our stock market research website can help you evaluate if ALNY is a good stock to buy).
- Execute your ALNY purchase: Decide if you will purchase ALNY shares at the current market price or use a limit order to purchase ALNY stock at a particular price.
- Keep tabs on your ALNY investment: Create a watchlist to important notifications about your investment in Alnylam Pharmaceuticals stock.
Step 1: Decide where to buy Alnylam Pharmaceuticals stock
You will need an online brokerage account in order to access the NASDAQ market and buy ALNY shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal details so you are able to buy ALNY stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create your new trading account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have opened your account on the best app for stock investing, you need to deposit funds:
Watch this video walkthrough to see the process of transferring money into your new brokerage account.
Step 4: Evaluate Alnylam Pharmaceuticals stock
After you have chosen the best place to buy Alnylam Pharmaceuticals stock, it's critical to analyze their stock prior to investing, so you can understand the risk as well as the opportunity.
Overview of key ALNY info
ALNY Fundamentals
WallStreetZen was created to help everyday investors do more accurate fundamental analysis quickly.
You can see all of the due diligence checks on ALNY's stock page.
Is ALNY stock properly valued?
Investors use many financial metrics, analyses, models, and charts to gauge ALNY's intrinsic value.
Using relative valuations ratios:
- ALNY may be overvalued based on its P/E ratio of 67.78x, relative to Biotechnology industry P/E ratio of 17.67x
- ALNY may be overvalued based on its P/B ratio of 36.69x, relative to Biotechnology industry P/B ratio of 4.86x
- ALNY may be overvalued based on its PEG ratio of 1.39x
You can access additional valuation analysis on ALNY's stock here.
ALNY Financial Health Overview
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the ALNY balance sheet.
- There are more short-term assets than short-term liabilities on the ALNY balance sheet.
- ALNY profit margin has gone up from -9.8% to 13.5% in the past year.
- ALNY's operating cash flow of $712.90M allows it to safely service it's debt of $2.97B.
Failed Financial Due Diligence Checks:
- ALNY has a relatively high debt to equity ratio of 3.77.
- Total ALNY debt is higher than 5 years ago, relative to shareholder equity.
- ALNY earnings of $869.67M is not enough to cover its interest payments.
Is it a good time to buy Alnylam Pharmaceuticals stock, according to Wall Street analysts?
Out of 15 sell side analysts who track ALNY, the consensus analyst rating on Alnylam Pharmaceuticals is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
Most Recent ALNY Analyst Upgrades/Downgrades
Keay Nakae, a top 5% analyst from Chardan Capital maintains ALNY with a strong buy rating and maintains their ALNY price target from $425.00 to $425.00, on Mar 25, 2026.
Faisal Khurshid, a top 10% analyst from Jefferies downgrades ALNY to a hold rating and lowers their ALNY price target from $522.00 to $330.00, on Mar 16, 2026.
Ilya Zubkov, a bottom 5% analyst from Freedom Broker upgrades ALNY to a strong buy rating and lowers their ALNY price target from $470.00 to $410.00, on Feb 17, 2026.
Whitney Ijem, a top 6% analyst from Canaccord Genuity maintains ALNY with a strong buy rating and raises their ALNY price target from $415.00 to $429.00, on Feb 17, 2026.
Canaccord Genuity's Whitney Ijem raised their price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) by 3.4% from $415 to $429 on 2026/02/17. The analyst maintained their Strong Buy rating on the stock.
Alnylam Pharmaceuticals reported its Q4 and FY 2025 earnings.
Ijem said they revised their model in light of the unremarkable results, which followed Alnylam Pharmaceuticals' 2026/01 preannouncement of modest top and bottom line miss
However, at a macro level, Amvuttra's launch in TTR is off to a great start, the analyst said, adding that management and the Street both expect upside going forward.
Earnings Report
Alnylam Pharmaceuticals reported:
For Q4 2025:
- EPS of $1.25, which beat the Zacks Consensus Estimate of $1.16 and Q4 2024’s $0.06.
- Revenue of $1.1B, which missed the Zacks Consensus Estimate by 3.35% but beat, by 85%, Q4 2024’s $593.17M.
For FY 2025:
- EPS of $5.08, compared to FY 2024 loss of $0.02.
- Revenue of $3.71B, up 65.2% Y/Y.
Management did not provide EPS and total revenue in its press release.
CEO Yvonne Greenstreet, M.D. commented: “2025 was a year of key accomplishments for Alnylam, highlighted by the landmark approval of AMVUTTRA for ATTR-CM in the U.S., which drove total net product revenues of nearly $3B, or 81% growth Y/Y, and propelled us to profitability.
“We also achieved great progress across our portfolio, initiating three Phase 3 studies, expanding our pipeline with four proprietary CTAs, and launching a potential best-in-class enzymatic ligation-based RNAi manufacturing platform.
“Further, we are excited to have recently unveiled our new set of five-year aspirational goals, Alnylam 2030, under which we aim to achieve global TTR leadership with a durable franchise; grow through innovation by delivering therapies that prevent, halt, or reverse disease; and scale with financial discipline and agility.
“By pursuing these ambitious goals, we believe Alnylam will drive substantial patient impact by addressing serious unmet medical needs around the world and create substantial long-term shareholder value.”
Joseph Stringer, a top 2% analyst from Needham maintains ALNY with a buy rating and lowers their ALNY price target from $529.00 to $510.00, on Feb 12, 2026.
You can dive deeper into what analysts are saying on the Alnylam Pharmaceuticals stock forecast page.
ALNY Trading Indicators
ALNY Earnings
Last year, ALNY revenue was $4.29B. During the past five year, ALNY's revenue has increased by 49.66% per year. This was faster than the Biotechnology industry average of 30.44%.
You can research ALNY's earnings and revenue performance here.
What are ALNY executives and large shareholders up to?
Over the last 12 months, executives and large shareholders at ALNY have sold more shares than they have bought.
Amy W. Schulman, Director of ALNY, was the latest ALNY insider to buy. They bought $789,750.00 worth of ALNY shares on May 13, 2026.
Get more info about who owns ALNY shares here.
Can I get consistent income from ALNY stock?
No, Alnylam Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your ALNY purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually fine for most investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a specific price, place a limit order.
Click the Open Trade button and your broker will place the order.
If you want more help with investing in stocks on eToro, click the helpful video below:
Step 6: Keep tabs on your ALNY investment
Now that you own some ALNY stock, you'll want to stay up-to-date on your shares.
Create a watchlist to get notified of the latest news about your ALNY stock.
ALNY Feed
How to Buy Stock in Alnylam Pharmaceuticals
To reiterate, here are the 6 steps to buy stock in Alnylam Pharmaceuticals:
- Decide where to buy Alnylam Pharmaceuticals stock
- Sign up for a brokerage account
- Deposit money your brokerage account
- Evaluate Alnylam Pharmaceuticals stock
- Execute your ALNY purchase
- Keep tabs on your ALNY investment
If you are looking for a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Alnylam Pharmaceuticals, add ALNY to your watchlist below.
Other Stock Buying Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.